TL
EIGR
TowerView LLC’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,000
| Closed | -$158K | – | 32 |
|
|
2022
Q2 | $158K | Sell |
25,000
-25,000
| -50% | -$158K | 0.08% | 27 |
|
|
2022
Q1 | $415K | Sell |
50,000
-85,000
| -63% | -$706K | 0.2% | 26 |
|
|
2021
Q4 | $701K | Hold |
135,000
| – | – | 0.35% | 25 |
|
|
2021
Q3 | $902K | Hold |
135,000
| – | – | 0.47% | 23 |
|
|
2021
Q2 | $1.15M | Sell |
135,000
-5,000
| -4% | -$42.6K | 0.69% | 19 |
|
|
2021
Q1 | $1.24M | Buy |
140,000
+10,000
| +8% | +$88.5K | 0.77% | 18 |
|
|
2020
Q4 | $1.6M | Buy |
130,000
+10,000
| +8% | +$123K | 1.14% | 11 |
|
|
2020
Q3 | $977K | Buy |
120,000
+42,500
| +55% | +$346K | 0.75% | 12 |
|
|
2020
Q2 | $744K | Buy |
+77,500
| New | +$744K | 0.57% | 13 |
|